Related Experiment Video
Updated: Aug 14, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Variability and immunogenicity of human immunodeficiency virus type 1 p24 gene quasispecies
1Divisions of Clinical Virology, F68, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden.
Abstract:
Despite the conserved nature of the human immunodeficiency virus type 1 (HIV-1) gag gene, multiple quasispecies of the p24 gene coexist in HIV-1-infected patients. We cloned and sequenced 31 p24 genes from four HIV-1-infected patients. The intrapatient homology between the p24 genes ranged from 97.1 to 99.1%, whereas the interpatient homology ranged from 91.5 to 93.8%, suggesting a host-specific evolution. Synonymous and nonsynonymous nucleotide changes were evenly distributed in the p24 gene, with 27 and 28%, respectively, located within host human leukocyte antigen class I recognition sites. This would suggest only a minor influence from the host cytotoxic T-cell response on the evolution of the p24 gene. The importance of minor variations within p24 was analyzed by designing DNA-based immunogens from two distinct p24 quasispecies genes simultaneously derived from one patient. In plasmid-immunized H-2(b), H-2(d), and H-2(k) haplotype mice, a clear influence from the host major histocompatibility complex was noted on the immune responses, fully consistent with those noted when a recombinant p24 protein is used as the immunogen. The two p24 DNA immunogens did not differ in their immunogenicity, indicating that the limited genetic variability (<1%) had little influence on the immune responses.
Insights
Human immunodeficiency virus type 1 (HIV-1) p24 gene evolution shows host-specific changes, but limited genetic variability (<1%) minimally impacts immune responses. This suggests host genetics, not minor viral variations, primarily shape immunity to HIV-1.
Area of Science:
- Virology
- Immunology
- Genetics
Background:
- Human immunodeficiency virus type 1 (HIV-1) gag gene is conserved, yet diverse p24 gene quasispecies exist within infected patients.
- Understanding HIV-1 p24 gene evolution and its impact on host immune response is crucial for vaccine development.
Purpose of the Study:
- To investigate the genetic variability of the HIV-1 p24 gene within and between patients.
- To assess the influence of host genetics, specifically major histocompatibility complex (MHC), on immune responses to HIV-1 p24.
- To determine the impact of minor genetic variations in p24 on immunogenicity.
Main Methods:
- Cloning and sequencing of 31 p24 genes from four HIV-1-infected patients.
- Analysis of intrapatient and interpatient homology.
- Design of DNA-based immunogens from distinct p24 quasispecies for plasmid immunization in mice with different MHC haplotypes (H-2b, H-2d, H-2k).
Main Results:
- High intrapatient homology (97.1-99.1%) and lower interpatient homology (91.5-93.8%) suggest host-specific HIV-1 evolution.
- Synonymous and nonsynonymous nucleotide changes were evenly distributed, with minimal influence from host cytotoxic T-cell response sites.
- Host MHC haplotype significantly influenced immune responses to p24 DNA immunogens, while limited genetic variability (<1%) did not affect immunogenicity.
Conclusions:
- HIV-1 p24 evolution is influenced by host-specific factors, but minor genetic variations (<1%) have minimal impact on immune responses.
- Host major histocompatibility complex plays a significant role in shaping the immune response to HIV-1 p24.
- These findings have implications for understanding HIV-1 persistence and designing effective immunotherapies or vaccines.
More Related Videos
14:23A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
11:19Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
Published on: May 4, 2015
Related Concept Videos
Viral Recombination
Viral Mutations
Inhibitors of Virion Maturation and Assembly